Valuation: Carmat

Market Cap 6.15M 6.98M 5.71M 5.24M 9.84M 674M 10M 67.89M 26.49M 331M 26.22M 25.66M 1.14B P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 59.25M 67.33M 55.08M 50.55M 94.9M 6.5B 96.44M 654M 255M 3.19B 253M 247M 11.03B EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 55 2016-08-31
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2025-03-31
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 2017-01-01
Director/Board Member 79 2017-04-19
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 7.08M
+3.54%+3.25%-18.16%+13.52% 127B
+1.92%-0.96%-2.69%-5.12% 12.79B
+0.95%-2.07%+62.86%+106.79% 9.02B
-6.12%-1.94%-49.75%-68.94% 4.39B
-0.21%-2.71%-0.62%+35.02% 2.63B
-2.59%-0.76%-18.40%-26.34% 1.59B
-3.05%-2.46%-26.43%-31.81% 1.58B
+3.72%-0.15%-1.85%-57.71% 1.56B
Average -0.20%-1.82%-6.88%-4.32% 20.02B
Weighted average by Cap. +2.81%+2.14%-12.87%+13.84%

Financials

2023 2024
Net sales 3.84M 4.36M 3.57M 3.27M 6.15M 421M 6.25M 42.38M 16.54M 206M 16.37M 16.02M 715M 7.34M 8.35M 6.83M 6.27M 11.76M 806M 11.95M 81.12M 31.66M 395M 31.33M 30.66M 1.37B
Net income -53.87M -61.22M -50.08M -45.96M -86.28M -5.91B -87.69M -595M -232M -2.9B -230M -225M -10.03B -51.4M -58.41M -47.78M -43.85M -82.32M -5.64B -83.66M -568M -222M -2.77B -219M -215M -9.57B
Net Debt 49.64M 56.41M 46.14M 42.35M 79.5M 5.45B 80.8M 548M 214M 2.67B 212M 207M 9.24B 53.1M 60.35M 49.36M 45.3M 85.05M 5.83B 86.44M 587M 229M 2.86B 227M 222M 9.89B
Logo Carmat
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
-